David Gandara and Julia Rotow
Jul 20, 2025, 12:10
David Gandara: Provocative Data Supporting Treatment Beyond Progression by Julia Rotow
David Gandara, Co-Director of the Center for Experimental Therapeutics at the UC Davis Comprehensive Cancer Center, shared a post on X:
“At NOSCM, Julia Rotow presents provocative data supporting continuation of EGFR TKIs after progressive disease, so-called treatment beyond progression (TBP).
I am increasingly a believer. Invariably there are residual sensitive clones which need to be controlled.”
More posts featuring Julia Rotow.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 20, 2025, 11:27
Jul 20, 2025, 11:17
Jul 20, 2025, 10:28
Jul 20, 2025, 10:28
Jul 20, 2025, 10:17
Jul 20, 2025, 10:08